In this study, we focused on the immunological functional heterogeneity of FOXP3 + TILs and evaluated the balance of eTreg and CD8 TILs as representative of the immunoprogressive and immunosuppressive power of TILs in patients with breast cancer. The gene discussed is FOXP3; the disease is breast carcinoma.